LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Phreesia Inc

Fechado

SetorSaúde

11.88 0.42

Visão Geral

Variação de preço das ações

24h

Atual

Mín

11.87

Máximo

12.3

Indicadores-chave

By Trading Economics

Rendimento

3.6M

4.3M

Vendas

3.1M

120M

Margem de lucro

3.549

Funcionários

2,082

EBITDA

6.1M

13M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+136.93% upside

Dividendos

By Dow Jones

Próximos Ganhos

11 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-469M

737M

Abertura anterior

11.46

Fecho anterior

11.88

Sentimento de Notícias

By Acuity

50%

50%

127 / 351 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

Phreesia Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de fev. de 2026, 23:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 de fev. de 2026, 23:45 UTC

Conversa de Mercado

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 de fev. de 2026, 23:40 UTC

Conversa de Mercado

Gold Falls on Possible Position Adjustments -- Market Talk

15 de fev. de 2026, 23:06 UTC

Ganhos

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 de fev. de 2026, 23:04 UTC

Ganhos

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 de fev. de 2026, 23:04 UTC

Ganhos

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 de fev. de 2026, 23:01 UTC

Ganhos

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 de fev. de 2026, 23:01 UTC

Ganhos

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 de fev. de 2026, 22:53 UTC

Aquisições, Fusões, Aquisições de Empresas

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 de fev. de 2026, 22:53 UTC

Aquisições, Fusões, Aquisições de Empresas

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 de fev. de 2026, 22:52 UTC

Aquisições, Fusões, Aquisições de Empresas

Qube Shareholders to Receive A$5.20/Share in Cash

15 de fev. de 2026, 22:52 UTC

Aquisições, Fusões, Aquisições de Empresas

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 de fev. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope CEO Tania Archibald Speaking on a Call With Media

15 de fev. de 2026, 22:17 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

15 de fev. de 2026, 22:16 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

15 de fev. de 2026, 22:14 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

15 de fev. de 2026, 22:14 UTC

Aquisições, Fusões, Aquisições de Empresas

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

15 de fev. de 2026, 20:48 UTC

Ganhos

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 de fev. de 2026, 20:47 UTC

Ganhos

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 de fev. de 2026, 20:46 UTC

Ganhos

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 de fev. de 2026, 20:45 UTC

Ganhos

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 de fev. de 2026, 20:44 UTC

Ganhos

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 de fev. de 2026, 20:44 UTC

Ganhos

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 de fev. de 2026, 20:43 UTC

Ganhos

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 de fev. de 2026, 20:42 UTC

Ganhos

BlueScope Net Debt A$2.2 Million at Dec. 31

15 de fev. de 2026, 20:42 UTC

Ganhos

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 de fev. de 2026, 20:41 UTC

Ganhos

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 de fev. de 2026, 20:40 UTC

Ganhos

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 de fev. de 2026, 20:40 UTC

Ganhos

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 de fev. de 2026, 20:39 UTC

Ganhos

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Comparação entre Pares

Variação de preço

Phreesia Inc Previsão

Preço-alvo

By TipRanks

136.93% parte superior

Previsão para 12 meses

Média 28.1 USD  136.93%

Máximo 35 USD

Mínimo 22 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para Phreesia Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

12 ratings

12

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

25.23 / 25.61Suporte e Resistência

Curto Prazo

Neutral Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

127 / 351 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat